Cargando…

Massive parallel RNA sequencing of highly purified mesenchymal elements in low-risk MDS reveals tissue-context-dependent activation of inflammatory programs

Detalles Bibliográficos
Autores principales:	Chen, S, Zambetti, N A, Bindels, E M J, Kenswill, K, Mylona, A M, Adisty, N M, Hoogenboezem, R M, Sanders, M A, Cremers, E M P, Westers, T M, Jansen, J H, van de Loosdrecht, A A, Raaijmakers, M H G P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240018/ https://www.ncbi.nlm.nih.gov/pubmed/27109510 http://dx.doi.org/10.1038/leu.2016.91

Ejemplares similares

Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes
por: Ping, Zhen, et al.
Publicado: (2018)

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
por: Valent, Peter, et al.
Publicado: (2017)

Dysregulation of developmental and cell type-specific expression of glycoconjugates on hematopoietic cells: a new characteristic of myelodysplastic neoplasms (MDS)
por: van Spronsen, Margot F., et al.
Publicado: (2023)

Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN
por: Mestrum, Stefan G. C., et al.
Publicado: (2020)

QCDSP: a teraflop scale massively parallel supercomputer
por: Chen, D, et al.
Publicado: (1997)

Massively parallel, computationally guided design of a proenzyme
por: Yachnin, Brahm J., et al.
Publicado: (2022)

Challenging the status flow: how artificial intelligence is advancing diagnosis of myelodysplastic neoplasms
por: Duetz, Carolien, et al.
Publicado: (2023)

Massively parallel functional dissection of mammalian enhancers in vivo
por: Patwardhan, Rupali P, et al.
Publicado: (2012)

Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)‐mutant myelodysplastic syndromes subtype
por: Duetz, Carolien, et al.
Publicado: (2021)

Accuracy and quality of massively parallel DNA pyrosequencing
por: Huse, Susan M, et al.
Publicado: (2007)

Targeted massively parallel sequencing for congenital generalized lipodystrophy
por: Costa-Riquetto, Aline D., et al.
Publicado: (2020)

A programmable method for massively parallel targeted sequencing
por: Hopmans, Erik S., et al.
Publicado: (2014)

Iron overload in myelodysplastic syndromes (MDS) – diagnosis, management, and response criteria: a proposal of the Austrian MDS platform
por: Valent, P, et al.
Publicado: (2008)

LHC MDS For 2018
por: Tomás, R, et al.
Publicado: (2019)

Massively Parallel Interrogation of Aptamer Sequence, Structure and Function
por: Fischer, Nicholas O., et al.
Publicado: (2008)

Statistical method to compare massive parallel sequencing pipelines
por: Elsensohn, MH., et al.
Publicado: (2017)

Multiplex Assessment of Protein Variant Abundance by Massively Parallel Sequencing
por: Matreyek, Kenneth A., et al.
Publicado: (2018)

Divergent Autologous T Cell Responses to Leukaemic Dendritic Cells during Remission in Acute Promyelocytic Leukaemia
por: Westers, Theresia M., et al.
Publicado: (2005)

A massively parallel screening platform for converting aptamers into molecular switches
por: Yoshikawa, Alex M., et al.
Publicado: (2023)

Massively parallel digital transcriptional profiling of single cells
por: Zheng, Grace X. Y., et al.
Publicado: (2017)

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT
por: Cremers, E. M. P., et al.
Publicado: (2016)

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
por: Kuendgen, A., et al.
Publicado: (2020)

Robustness of Massively Parallel Sequencing Platforms
por: Kavak, Pınar, et al.
Publicado: (2015)

Methods of massive parallel reporter assays for investigation of enhancers
por: Romanov, S.E., et al.
Publicado: (2021)

PB1922: EFFECTIVENESS OF AZACITIDINE IN FRONTLINE HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR MDS): A RETROSPECTIVE COHORT STUDY OF 382 PATIENTS
por: Rajakumaraswamy, N., et al.
Publicado: (2022)

Massively Parallel Single Amino Acid Mutagenesis
por: Kitzman, Jacob O., et al.
Publicado: (2015)

Massively Parallel Sequencing and Analysis of the Necator americanus Transcriptome
por: Cantacessi, Cinzia, et al.
Publicado: (2010)

Amplitude analysis of four-body decays using a massively-parallel fitting framework
por: Hasse, C., et al.
Publicado: (2017)

Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype
por: Sallman, David A., et al.
Publicado: (2016)

Massively parallel characterization of restriction endonucleases
por: Kamps-Hughes, Nick, et al.
Publicado: (2013)

An FPGA-Based Massively Parallel Neuromorphic Cortex Simulator
por: Wang, Runchun M., et al.
Publicado: (2018)

Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing
por: Huskova, H, et al.
Publicado: (2017)

Massively parallel rare disease genetics
por: Burns, Kathleen H, et al.
Publicado: (2011)

PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT-MDS-1)
por: DeZern, A., et al.
Publicado: (2022)

Constructing Neuronal Network Models in Massively Parallel Environments
por: Ippen, Tammo, et al.
Publicado: (2017)

Bogus "M.Ds."
por: Karnik, C. H.
Publicado: (1929)

Identification of radiation-induced microRNA transcriptome by next-generation massively parallel sequencing
por: Chaudhry, M. Ahmad, et al.
Publicado: (2013)

Genome-wide strand asymmetry in massively parallel reporter activity favors genic strands
por: Roberts, Brian S., et al.
Publicado: (2021)

Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling
por: Lareau, Caleb A., et al.
Publicado: (2020)

A massively parallel strategy for STR marker development, capture, and genotyping
por: Kistler, Logan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_80921gt8i2ds3a60tf0fojtbo7